Abstract
Molecular modeling (MM) study is performed for Pipecolic acid based derivatives (PSAs) of tumor necrosis factor-α converting enzyme (TACE) inhibitors because of their very high selectivity for TACE over MMP-1. MM study was carried out by Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular field Similarity Indices Analysis (CoMSIA) approaches. Computational docking simulations have also been performed to explore atomic details of TACE/PSA interactions and to identify the most important structural features of PSAs vital for TACE inhibitory activity. Molecular modeling study was performed using probable bioactive conformations, generated employing docking, for molecular alignment. The CoMSIA model resulted to be more predictive than CoMFA model, and gave conventional r2 0.996, r2cv 0.765, q2 0.783, SEE 0.025, F-value 472.149, r2boot 0.999 and r2test 0.788. Generated 3D-QSAR field contributions (contour maps) and results of docking analysis showed good correlation. Therefore, present studies will be useful for designing new molecules with improved TACE inhibitory activity in future.
Keywords: TACE inhibitors, Rheumatoid arthritis, CoMFA, CoMSIA, Docking, Converting Enzyme, Pipecolic Acid, TNF, necrosis, PSA, 3D-QSAR, cytokine, metalloproteinases, fusion
Letters in Drug Design & Discovery
Title: CoMFA and CoMSIA Analyses of Highly Selective Pipecolic Acid Based TNF-α Converting Enzyme (TACE) Inhibitors Using Docked Conformations for Molecular Alignment
Volume: 8 Issue: 5
Author(s): Malkeet Singh Bahia, Sukhvir Chand, Shravan Kumar Gunda, Shwetha Reddy Gade, Saikh Mahmood and Om Silakari
Affiliation:
Keywords: TACE inhibitors, Rheumatoid arthritis, CoMFA, CoMSIA, Docking, Converting Enzyme, Pipecolic Acid, TNF, necrosis, PSA, 3D-QSAR, cytokine, metalloproteinases, fusion
Abstract: Molecular modeling (MM) study is performed for Pipecolic acid based derivatives (PSAs) of tumor necrosis factor-α converting enzyme (TACE) inhibitors because of their very high selectivity for TACE over MMP-1. MM study was carried out by Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular field Similarity Indices Analysis (CoMSIA) approaches. Computational docking simulations have also been performed to explore atomic details of TACE/PSA interactions and to identify the most important structural features of PSAs vital for TACE inhibitory activity. Molecular modeling study was performed using probable bioactive conformations, generated employing docking, for molecular alignment. The CoMSIA model resulted to be more predictive than CoMFA model, and gave conventional r2 0.996, r2cv 0.765, q2 0.783, SEE 0.025, F-value 472.149, r2boot 0.999 and r2test 0.788. Generated 3D-QSAR field contributions (contour maps) and results of docking analysis showed good correlation. Therefore, present studies will be useful for designing new molecules with improved TACE inhibitory activity in future.
Export Options
About this article
Cite this article as:
Singh Bahia Malkeet, Chand Sukhvir, Kumar Gunda Shravan, Reddy Gade Shwetha, Mahmood Saikh and Silakari Om, CoMFA and CoMSIA Analyses of Highly Selective Pipecolic Acid Based TNF-α Converting Enzyme (TACE) Inhibitors Using Docked Conformations for Molecular Alignment, Letters in Drug Design & Discovery 2011; 8 (5) . https://dx.doi.org/10.2174/157018011795514195
DOI https://dx.doi.org/10.2174/157018011795514195 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phospholipase A2 Myotoxins from Bothrops Snake Venoms: Structure- Function Relationship
Current Organic Chemistry MicroRNAs in Colorectal Neoplasia: From Pathobiology to Clinical Applications
Current Pharmaceutical Biotechnology High Density DNA Microarrays: Algorithms and Biomedical Applications
Current Medicinal Chemistry Intravenous Immunoglobulın Therapy in Dermatology: An Update
Inflammation & Allergy - Drug Targets (Discontinued) Fibrinogen: A Predictor of Vascular Disease
Current Pharmaceutical Design Synthesis and Docking Study of Some Bioactive <i>N</i>-(benzo[<i>d</i>]thiazol-2-yl)- 2-(4-((substituted)phenoxy)acetamide on Cyclo-oxygenase-2 Enzyme and <i>In vivo</i> Analgesic Activity Evaluation
Letters in Drug Design & Discovery Metabolic Fate of Endocannabinoids
Current Neuropharmacology Mechanism of Anti-Tumor Effect by Curcumin in Hematological Malignancies
Current Pharmaceutical Analysis Severe Pancytopenia Following Single Dose Methotrexate In Psoriasis: A Rare And Potentially Lethal Manifestation
Current Drug Safety Does Parkinson’s Disease and Type-2 Diabetes Mellitus Present Common Pathophysiological Mechanisms and Treatments?
CNS & Neurological Disorders - Drug Targets III. Angiogenesis: Complexity of Tumor Vasculature and Microenvironment
Current Pharmaceutical Design What they are, How they Work and Why they do What they do? The Story of SV40-derived Gene Therapy Vectors and What They Have to Offer
Current Gene Therapy The Characteristics of Th1/Th2 Cytokine Receptors on Monocytes in Untreated Patients of Long Term Nonprogressor or Chronic HIV Infection
Current Molecular Medicine Adverse Reactions Induced by Minocycline: A Review of Literature
Current Drug Safety Neuron-Microglia Interactions in Motor Neuron Degeneration. The Inflammatory Hypothesis in Amyotrophic Lateral Sclerosis Revisited
Current Medicinal Chemistry Natural Products and Cancer Stem Cells
Current Pharmaceutical Design Recent Advances in the Design and Development of Anticancer Molecules based on PROTAC Technology
Current Medicinal Chemistry Immunological Targets in Inflammation from the Small Molecule Perspective
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Tumor Necrosis Factor-α, a Regulator and Therapeutic Agent on Breast Cancer
Current Pharmaceutical Biotechnology Harmonious Biomaterials for Development of In situ Approaches for Locoregional Delivery of Anti-cancer Drugs: Current Trends
Current Medicinal Chemistry